Mario Mastrangelo1, Flavia Chiarotti2, Luana Berillo3, Caterina Caputi4, Claudia Carducci5, Claudio Di Biasi6, Filippo Manti7, Francesca Nardecchia8, Vincenzo Leuzzi9. 1. Department of Paediatrics, Child Neurology and Psychiatry, Sapienza University of Rome. Electronic address: mario.mastrangelo@uniroma1.it. 2. Section of NeuroToxicology and Neuroendocrinology, Department of Cell Biology and Neuroscience, National Institute of Health, Rome. Electronic address: flavia.chiarotti@iss.it. 3. Department of Paediatrics, Child Neurology and Psychiatry, Sapienza University of Rome. Electronic address: luanaberillo@gmail.com. 4. Department of Paediatrics, Child Neurology and Psychiatry, Sapienza University of Rome. Electronic address: caputi.caterina@libero.it. 5. Department of Experimental Medicine, "Sapienza University of Rome". Electronic address: claudia.carducci@uniroma1.it. 6. Department of Emergency Radiology, "Sapienza University of Rome" 7. Department of Paediatrics, Child Neurology and Psychiatry, Sapienza University of Rome. Electronic address: mantifilippo@libero.it. 8. Department of Paediatrics, Child Neurology and Psychiatry, Sapienza University of Rome; Department of Physiology and Pharmacology, "Sapienza University of Rome". Electronic address: francesca.nardecchia@gmail.com. 9. Department of Paediatrics, Child Neurology and Psychiatry, Sapienza University of Rome. Electronic address: vincenzo.leuzzi@uniroma1.it.
Abstract
BACKGROUND: Pathogenesis and clinical consequences of white matter abnormalities on magnetic resonance imaging (MRI) in phenylketonuric (PKU) patients are incompletely known. OBJECTIVE: To study white matter alterations progression and outcome and its relationships with phenylalanine levels and intelligence quotient (IQ) in early treated PKU subjects who underwent serial MRIs during a prolonged follow-up. METHODS: 47 early treated PKU patients (mean age 25.1 ± 5.6 years; range 12-37 years) have been enrolled when two or more consecutive brain MRIs, a complete biochemical history, and MRI-concurrent blood phenylalanine levels were available. The severity and extension of white matter abnormalities were expressed in a computed score. Consecutive IQ assessments were available in 24 patients. We analyzed intra- and interindividual white matter alterations variations and their relationship with quality of biochemical control and cognitive outcome. RESULTS: Early treated PKU patients showed a high rate of white matter alterations with a relevant increase in frequency/severity from the second decade of life onwards. Age and quality of dietary control before or between subsequent examinations showed an independent cumulative effect on white matter alterations outcome. No significant association was found between white matter alterations and cognitive outcome. A remarkable interindividual variability was found and several patients disclosed incongruity between the trajectory of white matter alterations and biochemical control. About 30% of white matter alterations variability remains unexplained by the disease-associated determinants. CONCLUSIONS: The evolution of white matter alterations is not significantly affected by intellectual outcome and is affected by aging, chronic exposure to phenylalanine, and unknown individual factors.
BACKGROUND: Pathogenesis and clinical consequences of white matter abnormalities on magnetic resonance imaging (MRI) in phenylketonuric (PKU) patients are incompletely known. OBJECTIVE: To study white matter alterations progression and outcome and its relationships with phenylalanine levels and intelligence quotient (IQ) in early treated PKU subjects who underwent serial MRIs during a prolonged follow-up. METHODS: 47 early treated PKUpatients (mean age 25.1 ± 5.6 years; range 12-37 years) have been enrolled when two or more consecutive brain MRIs, a complete biochemical history, and MRI-concurrent blood phenylalanine levels were available. The severity and extension of white matter abnormalities were expressed in a computed score. Consecutive IQ assessments were available in 24 patients. We analyzed intra- and interindividual white matter alterations variations and their relationship with quality of biochemical control and cognitive outcome. RESULTS: Early treated PKUpatients showed a high rate of white matter alterations with a relevant increase in frequency/severity from the second decade of life onwards. Age and quality of dietary control before or between subsequent examinations showed an independent cumulative effect on white matter alterations outcome. No significant association was found between white matter alterations and cognitive outcome. A remarkable interindividual variability was found and several patients disclosed incongruity between the trajectory of white matter alterations and biochemical control. About 30% of white matter alterations variability remains unexplained by the disease-associated determinants. CONCLUSIONS: The evolution of white matter alterations is not significantly affected by intellectual outcome and is affected by aging, chronic exposure to phenylalanine, and unknown individual factors.
Authors: Susan E Waisbren; Sanjay P Prabhu; Patricia Greenstein; Carter Petty; Donald Schomer; Vera Anastasoaie; Kalin Charette; Daniel Rodriguez; Sai Merugumala; Alexander P Lin Journal: JIMD Rep Date: 2016-09-28
Authors: Amelie S Lotz-Havla; Sabrina Katzdobler; Brigitte Nuscher; Katharina Weiß; Johannes Levin; Joachim Havla; Esther M Maier Journal: Front Neurol Date: 2022-09-29 Impact factor: 4.086
Authors: Zoë Hawks; Anna M Hood; Dov B Lerman-Sinkoff; Joshua S Shimony; Jerrel Rutlin; Daniel Lagoni; Dorothy K Grange; Desirée A White Journal: Neuroimage Clin Date: 2019-07-02 Impact factor: 4.881
Authors: Amelie S Lotz-Havla; Katharina Weiß; Katharina Schiergens; Stephanie Regenauer-Vandewiele; Klaus G Parhofer; Tara Christmann; Luise Böhm; Joachim Havla; Esther M Maier Journal: Front Neurol Date: 2021-12-10 Impact factor: 4.003